US74587V1070
US74587V1070
Puma Biotechnology Inc
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 228.371.000 | 230.468.000 | 0.9% |
| Cost of Revenue | 58.157.000 | 64.404.000 | 9.7% |
| Gross Profit | 170.214.000 | 166.064.000 | 2.5% |
| 132.915.000 | 135.098.000 | 1.6% | |
| Operating Income | 37.299.000 | 30.966.000 | 20.5% |
| Pretax Income | 35.782.000 | 24.100.000 | 48.5% |
| Net Income Common Stockholders | 31.111.000 | 30.278.000 | 2.8% |
| -- | -- | -- | |
| -- | -- | -- |